Title : Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol.

Pub. Date : 2009 Apr

PMID : 20169010






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol. Cholesterol peroxisome proliferator activator receptor delta Mus musculus
2 Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol. Cholesterol peroxisome proliferator activator receptor delta Mus musculus
3 Peroxisome proliferator-activated receptor delta (PPARdelta) agonism increases HDL cholesterol and has therefore the potential to stimulate macrophage-to-feces reverse cholesterol transport (RCT). Cholesterol peroxisome proliferator activator receptor delta Mus musculus
4 Peroxisome proliferator-activated receptor delta (PPARdelta) agonism increases HDL cholesterol and has therefore the potential to stimulate macrophage-to-feces reverse cholesterol transport (RCT). Cholesterol peroxisome proliferator activator receptor delta Mus musculus
5 Peroxisome proliferator-activated receptor delta (PPARdelta) agonism increases HDL cholesterol and has therefore the potential to stimulate macrophage-to-feces reverse cholesterol transport (RCT). Cholesterol peroxisome proliferator activator receptor delta Mus musculus
6 Peroxisome proliferator-activated receptor delta (PPARdelta) agonism increases HDL cholesterol and has therefore the potential to stimulate macrophage-to-feces reverse cholesterol transport (RCT). Cholesterol peroxisome proliferator activator receptor delta Mus musculus
7 In conclusion, PPARdelta activation enhances excretion of macrophage or HDL-derived cholesterol in feces through reduced NPC1L1 expression in mice, comparable to the effect of ezetimibe. Cholesterol peroxisome proliferator activator receptor delta Mus musculus